Natus Medical Cash and Equivalents Trend

Natus Medical Incorporated -- USA Stock  

USD 29.05  0.4  1.4%

This module enables investors to look at Natus Medical various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 42.4 M, Cost of Revenue of 152.7 M or Earning Before Interest and Taxes EBIT of 56.5 M, but also many exotic indicators such as Interest Coverage of 194, Long Term Debt to Equity of 0.1056 or Calculated Tax Rate of 32.5157. This module is a perfect complement to use when analyzing Natus Medical Valuation or Volatility. It can also complement various Natus Medical Technical models. Check also analysis of Natus Medical Correlation with competitors.
Showing smoothed Cash and Equivalents of Natus Medical Incorporated with missing and latest data points interpolated. A component of Total Assets representing the amount of currency on hand as well as demand deposits with banks or financial institutions.
View

132.41 M

            10 Years Trend  
Increasing
Slightly volatile
 Cash and Equivalents 
      Timeline 

Natus Medical Cash and Equivalents Over Time

2016-12-31  213,551,000 
2017-12-31  213,551,000 
2018-12-31  132,410,000 

Other Fundumenentals

 

Regression Statistics

Arithmetic Mean  75,436,077
Geometric Mean  53,116,025
Coefficient Of Variation  91.3
Mean Deviation  52,344,107
Median  56,106,000
Standard Deviation  68,871,910
Range  201,635,000
R Value  0.78
R Squared  0.6
Significance  0.001835
Slope  13,716,275

Currently Trending

S   
 NYQ 
Purchased over 500 shares of
few hours ago ago
Traded for 5.3
F   
 NYQ 
Purchased over 200 shares of
few hours ago ago
Traded for 11.96
S   
 NYQ 
Purchased over 500 shares of
few hours ago ago
Traded for 5.3